0001209191-21-021781.txt : 20210318
0001209191-21-021781.hdr.sgml : 20210318
20210318165243
ACCESSION NUMBER: 0001209191-21-021781
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210317
FILED AS OF DATE: 20210318
DATE AS OF CHANGE: 20210318
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: JONKER JEFFREY DAVID
CENTRAL INDEX KEY: 0001589394
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39512
FILM NUMBER: 21754989
MAIL ADDRESS:
STREET 1: C/O NGM BIOPHARMACEUTICALS, INC.
STREET 2: 333 OYSTER POINT BLVD.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Metacrine, Inc.
CENTRAL INDEX KEY: 0001634379
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 472297384
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3985 SORRENTO VALLEY BLVD., SUITE C
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-369-7800
MAIL ADDRESS:
STREET 1: 3985 SORRENTO VALLEY BLVD., SUITE C
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-03-17
0
0001634379
Metacrine, Inc.
MTCR
0001589394
JONKER JEFFREY DAVID
C/O METACRINE, INC.
3985 SORRENTO VALLEY BLVD., SUITE C
SAN DIEGO
CA
92121
1
0
0
0
Stock Option (Right to Buy)
8.04
2021-03-17
4
A
0
33000
0.00
A
2031-03-16
Common Stock
33000
33000
D
The shares subject to the stock option shall vest in 36 equal monthly installments from the Vesting Commencement Date of March 17, 2021, subject to Reporting Person providing continuous service through such date.
/s/ Catherine C. Lee, Attorney-in-fact
2021-03-18